688656 Stock Overview
Operates as a in vitro diagnostic company in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
HOB Biotech Group Corp.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥99.35 |
| 52 Week High | CN¥165.21 |
| 52 Week Low | CN¥17.93 |
| Beta | -0.59 |
| 1 Month Change | -32.87% |
| 3 Month Change | 315.34% |
| 1 Year Change | 191.18% |
| 3 Year Change | 64.60% |
| 5 Year Change | n/a |
| Change since IPO | 55.23% |
Recent News & Updates
HOB Biotech Group Corp.,Ltd's (SHSE:688656) Popularity With Investors Under Threat As Stock Sinks 29%
Dec 23
HOB Biotech GroupLtd's (SHSE:688656) Anemic Earnings Might Be Worse Than You Think
Nov 04Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 43%
Oct 08Recent updates
HOB Biotech Group Corp.,Ltd's (SHSE:688656) Popularity With Investors Under Threat As Stock Sinks 29%
Dec 23HOB Biotech GroupLtd's (SHSE:688656) Anemic Earnings Might Be Worse Than You Think
Nov 04Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 43%
Oct 08Subdued Growth No Barrier To HOB Biotech Group Corp.,Ltd's (SHSE:688656) Price
Jul 04HOB Biotech GroupLtd's (SHSE:688656) Earnings Are Weaker Than They Seem
May 06Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 25%
Mar 08Shareholder Returns
| 688656 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -4.6% | -0.7% | 0.4% |
| 1Y | 191.2% | -18.4% | 12.3% |
Return vs Industry: 688656 exceeded the CN Biotechs industry which returned -18.4% over the past year.
Return vs Market: 688656 exceeded the CN Market which returned 12.3% over the past year.
Price Volatility
| 688656 volatility | |
|---|---|
| 688656 Average Weekly Movement | 20.0% |
| Biotechs Industry Average Movement | 8.9% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 688656's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 688656's weekly volatility has increased from 12% to 20% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 538 | John Li | www.hobiotech.com |
HOB Biotech Group Corp.,Ltd. operates as a in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immuno assays to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care.
HOB Biotech Group Corp.,Ltd Fundamentals Summary
| 688656 fundamental statistics | |
|---|---|
| Market cap | CN¥6.24b |
| Earnings (TTM) | CN¥35.26m |
| Revenue (TTM) | CN¥401.29m |
175.4x
P/E Ratio15.4x
P/S RatioIs 688656 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688656 income statement (TTM) | |
|---|---|
| Revenue | CN¥401.29m |
| Cost of Revenue | CN¥147.13m |
| Gross Profit | CN¥254.16m |
| Other Expenses | CN¥218.90m |
| Earnings | CN¥35.26m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.57 |
| Gross Margin | 63.34% |
| Net Profit Margin | 8.79% |
| Debt/Equity Ratio | 13.0% |
How did 688656 perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield72%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 08:41 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HOB Biotech Group Corp.,Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|